Dr. Myers retired from the Xerox Corporation in 2000 after a 36-year career in its research and development organizations. He was the senior vice president in charge of corporate research, advanced development, systems architecture, and corporate engineering from 1992 until his retirement. His responsibilities included the corporate research centers, PARC in Palo Alto, California, Webster Center for Research & Technology near Rochester, New York, Xerox Research Centre of Canada, Mississauga, Ontario, and the Xerox Research Centre of Europe in Cambridge, U.K., and Grenoble, France. During this period he was a member of the senior management committee in charge of setting the strategic direction of the company. Dr. Myers is chairman of the board of trustees of Earlham College and has held visiting faculty positions at the University of Rochester and at Stanford University. He holds a bachelor’s degree from Earlham College and a doctorate from Pennsylvania State University.

John H. Barton, Stanford University Law School

John H. Barton is George E. Osborne Professor of Law Emeritus at Stanford University, where he taught law and technology and a variety of international courses. He has concentrated for many years on the intellectual property aspects of biotechnology as well as on the relationships between intellectual property and antitrust law. Professor Barton recently chaired the United Kingdom Commission on Intellectual Property Rights, appointed by the U.K. Secretary of State for International Development to examine the impact of intellectual property rights on developing nations. He has also advised the World Health Organization, World Bank, U.S. Agency for International Development, and Rockefeller Foundation programs in agricultural biotechnology. He has been a chair of the Department of Agriculture’s National Genetic Resources Advisory Council and a member of the National Institutes of Health Recombinant DNA Advisory Committee and the National Institutes of Health Working Group on Research Tools.

Robert Blackburn, Chiron Corporation

Robert Blackburn is vice president and chief patent counsel of Chiron Corporation. With over 20 years of experience in both corporate and private practice, he has worked in biotechnology IP since its very early days. In the early 1980s he drafted the patent recently upheld in the CellPro litigation, and he successfully argued the Bell case (obviousness standard for new genes) in the Court of Appeals for the Federal Circuit. He has litigated biotechnology patents on four continents. On behalf of the Biotechnology Industry Organization and other industry coalitions he has been involved in legislative and policy matters, including the Biotechnology Process Patent Act, the GATT/TRIPS implementing legislation, the American Inventors Protection Act of 1999, and several amicus briefings of the Federal Circuit and the Supreme Court. The American Lawyer has named

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement